We are live on !
Find out more
TP
Traxis Partners Portfolio holdings
AUM
$129M
This Fund
S&P 500
This Quarter Est. Return
+6.75%
1 Year Est. Return
–
3 Year Est. Return
–
5 Year Est. Return
–
10 Year Est. Return
–
AUM
$129M
AUM Growth
–
Cap. Flow
+$127M
Cap. Flow % of AUM
Cap. Flow %
98%
Top 10 Holdings %
Top 10 Hldgs %
25.77%
Holding
61
New
61
Increased
–
Reduced
–
Closed
–
Avg Time Held
0
years
Top 10 Avg Time Held
0
years
Top 20 Avg Time Held
0
years
Top Buys
| Rank | Stock | Value |
|---|---|---|
| 1 |
HMA
HEALTH MGMT ASSOC INC CL-A
HMA
|
+$3.9M |
| 2 |
STJ
St Jude Medical
STJ
|
+$3.25M |
| 3 |
Molina Healthcare
MOH
|
+$3.18M |
| 4 |
Bristol-Myers Squibb
BMY
|
+$3.04M |
| 5 |
MDVN
MEDIVATION, INC.
MDVN
|
+$3.02M |
Top Sells
No sells this quarter
Sector Composition
| Rank | Sector | Weight |
|---|---|---|
| 1 | Healthcare | 88.17% |
| 2 | Miscellaneous | 6.43% |
| 3 | Financials | 2.46% |
| 4 | Industrials | 1.93% |
| 5 | Consumer Staples | 1.01% |
| Name | Market Value | Portfolio Weight | Shares or Principal |
Change in Stake | Capital Flow | Held Since | |
|---|---|---|---|---|---|---|---|
26
CVS Health
CVS
$118B
| $2.29M | 1.77% |
+40,000
| New | +$2.32M |
2013 Q2
0 quarters
|
|
27
Zimmer Biomet
ZBH
$18.5B
| $2.25M | 1.74% |
+30,900
| New | +$2.31M |
2013 Q2
0 quarters
|
|
28
Universal Health Services
UHS
$10.9B
| $2.21M | 1.71% |
+33,031
| New | +$2.18M |
2013 Q2
0 quarters
|
|
29
Cigna
CI
$80.7B
| $2.18M | 1.68% |
+30,000
| New | +$2.02M |
2013 Q2
0 quarters
|
|
30
Myriad Genetics
MYGN
$567M
| $2.15M | 1.66% |
+80,000
| New | +$2.32M |
2013 Q2
0 quarters
|
|
|
ESRX
31
DELISTED
Express Scripts Holding Company
ESRX
| $2.14M | 1.66% |
+34,716
| New | +$2.09M |
2013 Q2
0 quarters
|
|
|
AGN
32
DELISTED
Allergan Inc
AGN
| $2.11M | 1.63% |
+25,000
| New | +$2.59M |
2013 Q2
0 quarters
|
|
33
Merck
MRK
$347B
| $2.09M | 1.62% |
+47,160
| New | +$2.11M |
2013 Q2
0 quarters
|
|
34
Baxter International
BAX
$13B
| $2.06M | 1.6% |
+54,886
| New | +$2.1M |
2013 Q2
0 quarters
|
|
35
Accendra Health
ACH
$15.7M
| $2.03M | 1.57% |
+60,000
| New | +$1.99M |
2013 Q2
0 quarters
|
|
|
HRC
36
DELISTED
HILL-ROM HOLDINGS, INC.
HRC
| $2.01M | 1.55% |
+59,588
| New | +$2.09M |
2013 Q2
0 quarters
|
|
37
Acadia Healthcare
ACHC
$2.9B
| $1.97M | 1.53% |
+59,598
| New | +$1.93M |
2013 Q2
0 quarters
|
|
|
CFN
38
DELISTED
CAREFUSION CORPORATION
CFN
| $1.83M | 1.42% |
+49,649
| New | +$1.76M |
2013 Q2
0 quarters
|
|
39
Novartis
NVS
$292B
| $1.77M | 1.37% |
+27,900
| New | +$1.82M |
2013 Q2
0 quarters
|
|
|
CTRX
40
DELISTED
CATAMARAN CORP COM STK (CDA)
CTRX
| $1.7M | 1.31% |
+34,780
| New | +$1.81M |
2013 Q2
0 quarters
|
|
41
AbbVie
ABBV
$504B
| $1.65M | 1.28% |
+40,000
| New | +$1.75M |
2013 Q2
0 quarters
|
|
42
Stryker
SYK
$117B
| $1.62M | 1.25% |
+25,000
| New | +$1.66M |
2013 Q2
0 quarters
|
|
43
Vertex Pharmaceuticals
VRTX
$130B
| $1.6M | 1.24% |
+20,000
| New | +$1.47M |
2013 Q2
0 quarters
|
|
|
WMGI
44
DELISTED
Wright Medical Group Inc
WMGI
| $1.57M | 1.22% |
+60,000
| New | +$1.46M |
2013 Q2
0 quarters
|
|
|
HTWR
45
DELISTED
HEARTWARE INTERNATIONAL INC COM STK (DE)
HTWR
| $1.43M | 1.1% |
+15,000
| New | +$1.36M |
2013 Q2
0 quarters
|
|
|
TRNX
46
DELISTED
TORNIER N V SHARES (NLD)
TRNX
| $1.42M | 1.1% |
+81,000
| New | +$1.39M |
2013 Q2
0 quarters
|
|
47
Humana
HUM
$50.1B
| $1.35M | 1.04% |
+16,000
| New | +$1.26M |
2013 Q2
0 quarters
|
|
48
Idexx Laboratories
IDXX
$44.9B
| $1.34M | 1.04% |
+30,000
| New | +$1.31M |
2013 Q2
0 quarters
|
|
49
DELISTED
PALL CORP
PLL
| $1.33M | 1.03% |
+20,000
| New | +$1.35M |
2013 Q2
0 quarters
|
|
50
DELISTED
VCA Inc.
WOOF
| $1.3M | 1.01% |
+50,000
| New | +$1.21M |
2013 Q2
0 quarters
|
|
Similar funds
MIA
RRWJ
FLC
HSA
NM
Traxis Partners's Q2 2013 Portfolio in Review
Q2 2013 is the first quarter with a 13F filing on record for Traxis Partners, which disclosed 61 positions worth $129M. Its ten largest holdings account for 26% of the portfolio.
Its largest position is HEALTH MGMT ASSOC INC CL-A: 310,000 shares worth $4.87M.
By sector, the portfolio is most concentrated in Healthcare at 88% of assets, followed by Miscellaneous and Financials.
- Traxis Partners's largest Q2 2013 buy was HEALTH MGMT ASSOC INC CL-A: 310,000 shares worth $4.87M.
- Traxis Partners's ten largest holdings make up 26% of its $129M portfolio in Q2 2013.
- Traxis Partners disclosed 61 positions in Q2 2013, its first 13F filing on record.
Based on Traxis Partners's 13F filing for Q2 2013, filed 23 Jul 2013.